相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Cristina Taddei et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017
Maria Ganczak et al.
PLOS ONE (2020)
30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985-2016/17
Renata Cifkova et al.
PLOS ONE (2020)
Statins and PCSK9 inhibitors: A new lipid-lowering therapy
Enrique Gallego-Colon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
ANALYSIS OF INCIDENCE AND PREVALENCE OF CARDIOVASCULAR RISK FACTORS AND EVALUATION OF THEIR CONTROL IN EPIDEMIOLOGICAL SURVEY IN THE CZECH REPUBLIC
Zdenek Chmelik et al.
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2020)
Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to Go
Maciej Banach et al.
JAMA NETWORK OPEN (2020)
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
Jacek J. Jozwiak et al.
ATHEROSCLEROSIS SUPPLEMENTS (2020)
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study
Stephanie L. Harrison et al.
ATHEROSCLEROSIS (2020)
Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion
Narine K. Movsisyan et al.
ANNALS OF GLOBAL HEALTH (2020)
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Guy De Backer et al.
ATHEROSCLEROSIS (2019)
Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes - Data from the TERCET registry with 19,287 patients
Krzysztof Dyrbus et al.
PHARMACOLOGICAL RESEARCH (2019)
Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study
Ivo Petrov et al.
ADVANCES IN THERAPY (2019)
Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study
Jean Ferrieres et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey
Delphine De Smedt et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
Nicolas Danchin et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia A systematic review and meta-analysis
Hye Duck Choi et al.
MEDICINE (2018)
Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study
Rongjing Ding et al.
JOURNAL OF GLOBAL HEALTH (2017)
Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries - Findings from the EUROASPIRE IV survey
Z. Reiner et al.
ATHEROSCLEROSIS (2016)
Cardiovascular disease in Europe: epidemiological update 2016
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries
Min Zhao et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey
Zeljko Reiner et al.
ATHEROSCLEROSIS (2013)
An International Model to Predict Recurrent Cardiovascular Disease
Peter W. F. Wilson et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study
Tomasz Tomasik et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2011)
Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey
Zeljko Reiner et al.
ATHEROSCLEROSIS (2010)
Optimal lipid modification: the rationale for combination therapy
James Backes et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization - A propensity analysis
HD Aronow et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
分享论文
